Trials / Conditions / Human African Trypanosomiasis

Human African Trypanosomiasis

8 registered clinical trials studyying Human African Trypanosomiasis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT) NCT06356974	Drugs for Neglected Diseases	Phase 3
Completed	Assessment of Recombinant HAT-RDT Specificity NCT05637632	Institute of Tropical Medicine, Belgium	—
Completed	Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis NCT05466630	Institut de Recherche pour le Developpement	N/A
Withdrawn	Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria NCT03394976	Foundation for Innovative New Diagnostics, Switzerland	—
Completed	Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monit NCT04099628	Institut de Recherche pour le Developpement	N/A
Completed	Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fev NCT01766830	University Hospital, Geneva	N/A
Completed	Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole NCT00982904	Drugs for Neglected Diseases	Phase 1
Completed	Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) NCT00906880	Drugs for Neglected Diseases	Phase 4